Avita Medical | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Celltrion KRW 442.87B 100.93B 2025-03
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 881.7M 14.5M 2024-12
CSL USD 4.28B 939M 2024-12
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Divis Laboratories Ltd 16.04B 2.07B 2025-03
Kangmei Pharma CNY 223.73M 38.54M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Mayne Pharma AUD 115.99M 63.1M 2024-06
Medical Developments International AUD 14.72M 1.36M 2024-12
Nanosonics AUD 73.44M 38.94M 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pacific Edge 283K 0 2024-03
Paradigm Biopharmaceuticals AUD 414.94K 4.82M 2024-12
Pharma Mar EUR 35.46M 11.59M 2025-03
Polynovo AUD 23.26M 22.74M 2024-06
PYC Therapeutics AUD 6.58M 2.13M 2024-06
Qiagen NV USD 308.68M 41.12M 2025-03
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 751.28M 34.06M 2024-12
Sartorius EUR 431M 36.4M 2025-03
Sino Biopharmaceutical CNY 10.5B 3.99B 2024-12
Telix Pharmaceuticals AUD 225.7M 52.36M 2024-06
Tilray USD 61.22M 1.51M 2024-11
Zz Pientze Pharmaceu 1.39B 632.84M 2025-03



Avita Medical Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jun 2025.